You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 24, 2024

Details for New Drug Application (NDA): 017478

✉ Email this page to a colleague

« Back to Dashboard

NDA 017478 describes GALLIUM CITRATE GA 67, which is a drug marketed by Curium, Ge Healthcare, and Lantheus Medcl, and is included in three NDAs. It is available from one supplier. Additional details are available on the GALLIUM CITRATE GA 67 profile page.

The generic ingredient in GALLIUM CITRATE GA 67 is gallium citrate ga-67. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the gallium citrate ga-67 profile page.
Summary for 017478
Applicant:Lantheus Medcl
Ingredient:gallium citrate ga-67
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2mCi/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.